Company: SCLXW
Filing Date: 2025-12-16
Form Type: S-1
Source: 0001193125-25-319720
Chunk: 241

Company: Scilex Holding Co
Filing Date: 2025-12-16
Form: S-1
Chunk 241
---
 cash used for investing activities                   |     |              |  (2,675 | ) |     |              |    (330 | ) |     |              |    (700 | ) |     |               |  (2,480 | ) |
| Net cash used for financing activities                   |     |              | (18,131 | ) |     |              |  25,582 |   |     |              | (22,981 | ) |     |               | (10,948 | ) |
| Net change in cash, cash equivalents and restricted cash |     | $            |  (1,457 | ) |     | $            |   2,545 |   |     | $            |  (2,394 | ) |     | $             |   3,387 |   |

**Cash Flows from Operating Activities For the year ended December 31, 2024, net cash proceeds from operating activities was approximately $19.3 million, attributable to non-cashreconciling items of $27.3 million related to allocated expense for financial instruments at fair value, stock-based compensation, change in fair value of debt and liability instruments, allowances for expected credit losses, depreciation and amortization, non-cashoperating lease cost and gain on derivative liabilities, and changes in operating assets and liabilities that provided $64.8 million of cash, partially offset by our net loss of $72.8 million. 158

For the year ended December 31, 2023, net cash used for operating activities was approximately $20.7 million, attributable to our net loss of $114.3 million, partially offset by other non-cash reconciling items of $27.9 million related to loss on derivative liabilities, stock-based compensation, change in fair value of debt and liability instruments, depreciation and amortization and non-cash operating lease cost, and changes in operating assets and liabilities that provided $65.7 million of cash.

For the nine months ended September 30, 2025, net cash proceeds from operating activities were approximately $21.3 million, attributable to the changes in operating assets and liabilities that provided $98.3 million of cash and other non-cash reconciling items of $250.9 million related to transaction costs expensed related to Semnur Business Combination, stock-based compensation, change in fair value of debt and liability instruments, change in fair value of equity investments, change in fair value of digital assets and equity investments, financing costs,